41 - Association of Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers on LVAD Support and Risk of Gastrointestinal Bleeding: A Multi-Center Analysis
Presentation Number
41
Session Name
SESSION 10 - ORAL: Gastrointestinal Bleeding in MCS Patients
Date
Wed, Apr 22, 2020
Time
02:00 PM - 03:45 PM
Authors
- J. Schultz, Minneapolis, MN, United States of America
- B. Trachtenberg, Houston, TX, United States of America
- J. Estep, Cleveland, OH, United States of America
- K. Goodwin, Minneapolis, MN, United States of America
- R. Araujo, Houston, TX, United States of America
- A. El Rafei, Minneapolis, MN, United States of America
- M. Pritzker, Minneapolis, MN, United States of America
- F. Kamdar, Minneapolis, MN, United States of America
- R. John, Minneapolis, MN, United States of America
- R. Cogswell, Minneapolis, MN, United States of America